Apigenin reduces the suppressive effect of exosomes derived from irritable bowel syndrome patients on the autophagy of human colon epithelial cells by promoting ATG14
Abstract Background Inflammatory bowel disease (IBS) is a chronic disorder of the gastrointestinal tract. Exosomes have been involved in various pathological processes including IBS. Apigenin has been reported to suppress inflammatory bowel disease (IBS). However, the regulatory roles of exosomes de...
Main Authors: | Rui Fu, Saiyue Liu, Mingjin Zhu, Jiajie Zhu, Mingxian Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-023-02963-5 |
Similar Items
-
Role of antispasmodics in the treatment of irritable bowel syndrome
by: V. N. Drozdov, et al.
Published: (2021-05-01) -
Epigenetic Mechanisms in Irritable Bowel Syndrome
by: Swapna Mahurkar-Joshi, et al.
Published: (2020-08-01) -
The Effects of Apigenin and Curcumin on Autophagy Related Cell Death and Apoptosis
by: Sera Kayacan, et al.
Published: (2018-12-01) -
Is fecal calprotectin always normal in children with irritable bowel syndrome?
by: You Jin Choi, et al.
Published: (2019-10-01) -
Prevalence of irritable bowel syndrome in endometriosis patients: A cross-sectional study
by: Nashwa Aldardier, et al.
Published: (2024-11-01)